# High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage

> **NCT01077206** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 255 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01077206
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2015-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01077206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01077206, "High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01077206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*